Moran v. Bondi Sands Inc.

Background

Michelle Moran alleged that she purchased Bondi Sands’ aerosol fragrance-free sunscreen in the summer of 2021. The product’s front label described it as “Reef Friendly.” Moran alleged that this statement led her to believe all of the product’s ingredients were safe for reefs and could not harm coral reefs or marine life. She further alleged that the products contained chemical ingredients, including avobenzone, homosalate, octisalate, and octocrylene, that can harm or kill reefs and marine life.

Moran alleged that she would not have purchased the product, or would have paid substantially less for it, had she known the truth. She also alleged that she continued to see products bearing the “Reef Friendly” statement and would like to purchase them in the future if the statement were true, but lacked specialized knowledge that would allow her to determine whether the representation was accurate.

She sought relief under each prong of California’s Unfair Competition Law, California’s False Advertising Law, and the California Consumer Legal Remedies Act. She also asserted breach-of-warranty and unjust-enrichment claims on behalf of herself and proposed classes.

Bondi Sands’ motion

Bondi Sands moved to dismiss or stay the case under the primary-jurisdiction doctrine, which allows a court to pause or dismiss a case without prejudice while an administrative agency addresses an issue within the agency’s special expertise. The court recognized that the Food and Drug Administration regulates over-the-counter sunscreen labeling and that proposed federal legislation could address “Reef Safe” labeling. But the proposed legislation had not passed, and agency action appeared too uncertain and remote to justify delaying the case. The court therefore denied in part the motion on that ground.

Bondi Sands also argued that the Food, Drug, and Cosmetic Act preempted Moran’s claims. Federal preemption can prevent state law from imposing labeling requirements that differ from or add to federal requirements. The court found that the federal sunscreen regulations did not currently address environmental claims. It concluded that Moran’s claims were not preempted in their entirety because they were based on the theory that “Reef Friendly” was misleading, and federal regulations prohibit false or misleading sunscreen claims. The court therefore denied in part the motion on the preemption issue.

Sufficiency of the claims

Bondi Sands argued that Moran was improperly asserting a “lack of substantiation” claim. Under California law, the court explained, there is no private right to sue merely because an advertising claim lacks supporting evidence. Moran instead maintained that the “Reef Friendly” statement was actually false. The court examined whether the complaint alleged facts supporting falsity rather than merely asserting that no evidence supported the statement.

The court concluded that Moran cited scientific materials, reports, petitions to the Food and Drug Administration, and legislation that she claimed supported her allegation that the products’ chemicals could harm reefs. The court found these allegations sufficiently identified facts that directly conflicted with the “Reef Friendly” representation. Whether Moran could ultimately prove the chemicals were dangerous was a question for a later stage, not a reason to dismiss the claims at the pleading stage. The court therefore denied in part Bondi Sands’ motion to dismiss the consumer-protection claims.

Bondi Sands challenged Moran’s breach-of-warranty and unjust-enrichment claims only on the ground that they depended on the consumer-protection claims. Because the court allowed the consumer-protection claims to proceed, it also denied Bondi Sands’ motion to dismiss the derivative warranty and unjust-enrichment claims.

Equitable-relief allegations

Bondi Sands argued that Moran had an adequate remedy through money damages and therefore could not seek equitable relief. The court explained that California’s Unfair Competition Law and False Advertising Law limit relief to restitution and injunctions, while the Consumer Legal Remedies Act permits both equitable relief and damages. Federal courts generally require a plaintiff seeking equitable relief to show that legal remedies are inadequate.

The court found that Moran had plausibly alleged a need for prospective injunctive relief because damages for past purchases would not necessarily ensure that she and other consumers could rely on the labeling in the future. But the court found her allegations insufficient to show that monetary remedies were inadequate. Her allegations about the procedural posture, the lack of expert discovery, possible differences between restitution and damages, and different limitations periods did not establish that damages were inherently inadequate. The court granted in part Bondi Sands’ motion to dismiss on this basis and granted Moran leave to amend because it could not conclude that amendment would be futile.

Standing and disposition

Standing is the requirement that a plaintiff show a concrete injury and, for an injunction, a sufficient likelihood of future harm. The court found that Moran adequately alleged an injury from purchasing the product based on the “Reef Friendly” representation. It also found that she plausibly alleged standing to seek an injunction because she claimed she lacked the specialized knowledge needed to determine whether the representation was true if she encountered the products again. The court therefore denied Bondi Sands’ motion to dismiss for lack of standing.

Judge Jeffrey White’s order granted in part and denied in part Bondi Sands’ motion to dismiss. The court gave Moran until May 20, 2022, to file a second amended complaint addressing the amendments covered by the parties’ stipulation and, if she wished, the allegations concerning monetary equitable relief. Bondi Sands was ordered to answer or otherwise respond by June 3, 2022, subject to a possible agreed extension. The parties were also ordered to appear for a case-management conference.